Single Use Bioprocessing Market Size, Share, Growth Analysis, By Product (Equipment, Single-Use Bioreactors), By Application (Filtration, Cell Culture), By Region - Industry Forecast 2024-2031

Global Single Use Bioprocessing Market size was valued at USD 13.5 billion in 2022 and is poised to grow from USD 15.46 billion in 2023 to USD 45.66 billion by 2031, growing at a CAGR of 14.5% during the forecast period (2024-2031).

The global single-use bioprocessing market is poised for significant growth, driven by the decreasing capital costs and shortened facility construction times associated with single-use technologies. The rising adoption of disposable products in bioprocessing, complemented by continuous innovations, is further propelling market expansion. Notably, ILC Dover LP's launch of liquid single-use bioprocessing bags in May 2022 showcases the industry's commitment to advancing product offerings. An increase in vendors supplying robust disposables and biopharmaceuticals will also stimulate demand. Additionally, integrating innovative automation solutions and leveraging big data analytics are expected to enhance operational efficiency in the bioprocessing sector, positively influencing market dynamics in the coming years. Overall, these factors create a conducive environment for sustained growth in the single-use bioprocessing market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Use Bioprocessing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Use Bioprocessing Market Segmental Analysis

Global Single Use Bioprocessing Market is segmented by product, application, workflow, molecule type, end user and region. Based on product, the market is segmented into equipment and consumables. Based on application, the market is segmented into filtration, cell culture, mixing, purification, storage & transfer and other. Based on workflow, the market is segmented into upstream bioprocessing and downstream bioprocessing. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins & peptides and cell & gene therapies. Based on end user, the market is segmented into pharmaceutical & biotechnology companies, CROS & CMOS and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Single Use Bioprocessing Market

The global single-use bioprocessing market is poised for significant growth driven by the expanding elderly population worldwide. The United Nations reports that in 2020, approximately 727 million individuals were aged 65 and older, a figure projected to nearly double to 1.5 billion by 2050. This demographic shift is likely to elevate the demand for biopharmaceuticals due to the increasing healthcare needs of older adults. Additionally, major corporations are increasingly prioritizing the enhancement of efficiency and cost-effectiveness in single-use systems, further propelling the market. This convergence of factors positions the single-use bioprocessing market for robust expansion over the coming years.

Restraints in the Global Single Use Bioprocessing Market

The global single-use bioprocessing market may face significant challenges due to strict government regulations and guidelines aimed at preventing contamination in various bioprocessing systems. These regulations highlight concerns regarding leachables and extractables associated with single-use components, which could impede market expansion during the forecast period. As stakeholders in the industry grapple with these regulatory hurdles, the apprehensions surrounding the safety and efficacy of single-use systems are expected to adversely affect market growth. Such challenges present considerable obstacles that could limit the adoption of single-use technologies in bioprocessing applications in the foreseeable future.

Market Trends of the Global Single Use Bioprocessing Market

The global single-use bioprocessing market is experiencing a significant upward trend driven by ongoing innovations and advancements in technology. An increase in research and development investments has catalyzed the design of cutting-edge single-use systems, further fueling market expansion. Notable activities, such as the launch of large-capacity HyPerforma single-use bioreactors by Thermo Fisher Scientific in March 2021, underscore the commitment of industry leaders to enhance production efficiency. Additionally, the growing preference for disposable systems among biopharmaceutical companies aims to address contamination risks and operational scalability, positioning the market for substantial growth in the foreseeable future.